mRNA therapeutics and Vaccines market Research Report by 2022, Forecast till 2035
Roots Analysis has done a detailed study on “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
With over 195 candidates under development, mRNA therapeutics and mRNA Vaccines Market currently represents one of the fastest growing drug classes in the pharmaceutical market
The pipeline features several drugs, which are being investigated across different phases of development; over 75% of the pipeline candidates are designed for delivery via the intramuscular and intravenous routes
Stakeholders are actively upgrading their existing capabilities to further enhance their respective product pipeline and comply to the evolving industry benchmarks
Presently, around 17 start-ups are driving innovation in this domain; various R&D initiatives have been undertaken by these players over the last few years
More than 345,000 patients have been recruited / enrolled in clinical trials registered for this novel class of therapies, across different geographies
Over 430 patents related to mRNA therapeutics and vaccines have recently been filed / granted by industry and non-industry stakeholders, indicating the widening intellectual capital in this domain
The growing interest is evident from the rise in partnership activity, since 2021; clinical trial agreements has emerged as the most common type of partnership model adopted by drug developers
Several investors, having realized the opportunity within this upcoming segment, have invested over USD 11 billion across various funding rounds in the past nine years
Big pharma players have undertaken several initiatives, ranging from proprietary product development to strategic investments, to tap the lucrative opportunity in this rapidly growing market
The market’s evolution is likely to be driven by the rising need for novel drug candidates; we expect the future opportunity to be well distributed across various routes of administration, therapeutic areas and key regions
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. mRNA Therapeutics
3.2.1. Advantages of mRNA Therapeutics
3.2.2. Key Applications of mRNA Therapeutics
3.3. mRNA Vaccines
3.4. mRNA Delivery Routes
3.5. mRNA Delivery Strategies
3.6. Key Challenges Associated with mRNA Therapeutics and Vaccines
3.7. Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. mRNA Therapeutics and Vaccines: Overall Market Overview
5. COMPETITIVE LANDSCAPE
5.1. mRNA Therapeutics and Vaccines: List of Developers
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Key Assumptions and Parameters
6.3. Methodology
6.4. mRNA Therapeutics and Vaccines Developers: Company Competitive Analysis
6.5. mRNA Therapeutics and Vaccines Developers based in North America
6.6. mRNA Therapeutics and Vaccines Developers based in Europe
6.7. mRNA Therapeutics and Vaccines Developers based in Asia-Pacific and Rest of the World
7. DRUG PROFILES
7.1. Chapter Overview
7.2. BNT162b2 (BioNTech / Pfizer)
7.3. GEMCOVAC-19 (Gennova)
7.4. mRNA-1273 (Moderna)
7.5. LUNAR-COV19 (Arcturus Therapeutics)
7.6. CVnCOV (CureVac)
7.7. mRNA-1010 (Moderna)
7.8. mRNA-1345 (Moderna)
7.9. mRNA-1647 (Moderna)
7.10. ARCoV (Walvax)
8. BIG PHARMA INITIATIVES
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. mRNA Related Initiatives of Big Pharmaceutical Players
8.4. Benchmark Analysis of Big Pharmaceutical Players
9. START-UP HEALTH INDEXING
9.1. Chapter Overview
9.2. Start-ups focused on mRNA Therapeutics and Vaccines
9.3. Benchmarking of Start-ups
9.4. Startup-Health Indexing
10. CLINICAL TRIAL ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. mRNA Therapeutics and Vaccines: Clinical Trial Analysis
11. PARTNERSHIPS AND COLLABORATIONS
11.1. Chapter Overview
11.2. Partnership Models
11.3. mRNA Therapeutics and Vaccines: Partnerships and Collaborations
12. FUNDING AND INVESTMENT ANALYSIS
12.1. Chapter Overview
12.2. Types of Funding
12.3. mRNA Therapeutics and Vaccines: Funding and Investment
13. PATENT ANALYSIS
13.1. Chapter Overview
13.2. Scope and Methodology
13.3. mRNA Therapeutics and Vaccines: Patent Analysis
13.4. mRNA Therapeutics and Vaccines: Patent Benchmarking Analysis
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Global mRNA Therapeutics and Vaccines Market, 2022-2035
14.4. mRNA Therapeutics and Vaccines Market: Value Creation Analysis
14.5. mRNA Therapeutics and Vaccines Market: Product-wise Sales Forecasts
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. eTheRNA Immunotherapies
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/mrna-therape
You may also be interested in the following titles:
Women’s Digital Health Market
Modular Manufacturing Facilities Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#mrna therapeutics and Vaccines Market #mrnatherapeuticsandvaccinesmarketgrowth #mrnavaccines #mrnabasedvaccines #mrnatherapeutics
Global Transient Protection Diodes Market Size and Forecast (2023-2031) | #transient Protection Diodes Market Size # Transient Protection Diodes Market Share # Transient Protection Diodes Market Growth # Transient Protection Diodes Market Opportunity # Transient Protection Diodes Market Research # Transient Protection Diodes Market Scope # Transient Protection Diodes Market Forecast
Automatic Sampling market Research Report by 2022, Forecast till 2035
The “Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA, 2022-2035’’ report features an extensive study on the current and future potential of automatic sampling systems
Key Inclusions
A detailed assessment of the current market landscape of automatic sampling systems, featuring a detailed analysis of these systems based on several parameters, such as type of monitoring method, type of sampling unit(s), availability of pump / probe, type of module, automated software, type of vessel, vessel fabrication material, type of analyte monitored, type of analyzer, number of sampling vessels, working volume, operating temperature, end user industry, scalability and applications of the system. In addition, the chapter includes analysis of automatic sampling system manufacturers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of systems being offered).
Over 400 patents related to automatic sampling in biopharmaceutical industry have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field
A competitiveness analysis of automatic sampling systems manufacturers based on various relevant parameters, such as overall experience of the company (in terms of number of years since it was established), product portfolio strength (in terms of number of automatic sampling systems manufactured and type of monitoring method) and portfolio diversity (in terms of type of sampling unit, end user industry, scalability and applications).
Elaborate profiles of prominent players engaged in this domain. Each profile includes a brief overview of the company, details related to its financial information (if available), information on product portfolio, recent developments and an informed future outlook.
A detailed market landscape of automatic sample collection / preparation systems, based on a several relevant parameters, such as system category, system classification, type of monitoring method, type of sampling unit, type of module, working volume, type of analyzer, end user industry and scalability of the products. In addition, the chapter includes a list of players engaged in developing automatic sample collection / preparation systems along with information on their year of establishment, company size, location of headquarters. Further, it also highlights the leading manufacturers of automatic sample collection / preparation systems (in terms of the number of systems manufactured).
Detailed profiles of the players offering automatic sample collection / preparation systems. It includes a brief overview of the company, details of its product portfolio, and a section on recent developments and an informed future outlook.
An insightful analysis of the patents filed / granted for automatic sampling systems, since 2016, taking into consideration various relevant parameters, such as type of patent, publication year, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed in the given time period) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.
An analysis of various developments / recent trends related to automatic sampling systems, offering insights on recent global events related to automatic sampling systems, and partnerships and collaborations established within the industry.
A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall automatic sampling systems market.
A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats of new entrants, bargaining power of customers, bargaining power of automatic sampling system manufacturers, threats of substitute products and rivalry among existing competitors.
The Automatic sampling market report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Monitoring Method
On-line
Off-line
At-line
Bioprocessing Method
Upstream
Downstream
Working Volume
Less than 10 mL
10-50 mL
51-100 mL
More than 100 mL
Scalability
Lab
Pilot
Commercial
Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World
Key Questions Answered
• Who are the key players engaged in the development of automatic sampling systems?
• What is the relative competitiveness of different automatic sampling system manufacturers?
• Who are the leading manufacturers involved in the automatic sample collection / preparation systems market?
• How has the intellectual property landscape of automatic sampling systems evolved over the years?
• What are the key agenda items being discussed in the various global events / conferences related to automatic sampling systems?
• Which partnership models are most commonly adopted by stakeholders engaged in the automatic sampling industry?
• How is the current and future market opportunity, likely to be distributed across key market segments?
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/automatic-sa
You may also be interested in the following titles:
Lab Automation Market
Digital Biomanufacturing Market
You may also like to learn what our experts are sharing in Roots educational series:
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Digital Therapies: The “Digital Pills” of current generation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
#automaticsamplingmarket #automaticsamplingmarketsize #automaticsamplinginbiopharmaceuticals #asepticsampling #samplingmarket
Exosome Therapeutics market Growth Opportunity and Industry Forecast to 2035
Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies, claims Roots Analysis
Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Type of Therapeutic
Allogeneic Therapy
AutologousTherapy
Target Indication(s)
Degenerative Meniscal Injury
Dystrophic Epidermolysis Bullosa
Fistula Perianal
Retinitis Pigmentosa
Therapeutic Area
Dermatological Disorders
Muscoskeletal Disorders
Ophthalmic Diseases
Rectal Disorders
Route of Administration
Fistula Tract
Intra-articular
Intra-ocular
Geography
North America
Europe
Asia-Pacific and Rest of the World
The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:
Codiak BioSciences
Coya Therapeutics
Curexsys
EV Therapeutics
Evox Therapeutics
SHIFTBIO
AEGLE Therapeutics
AVEM Healthcare
Cellular Biomedicine Group
OBCTCD24
ReNeuron
Stem Cell Medicine
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Drug Profiles
7. Clinical Trial Analysis
8. Academic Grants Analysis
9. Global Event Analysis
10. Partnerships and Collaborations
11. Funding and Investments
12. Start-up Health Indexing
13. Case Study: Exosome Development and Manufacturing Service Providers
14. Drug Failure Analysis
15. Market Forecast
16. Executive Insights
17. Appendix 1: Tabulated Data
18. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/exosome-ther
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market
Global Antibiotics Market
You may also like to learn what our experts are sharing in Roots educational series:
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
Exploring How Artificial Intelligence Is Transforming Digital Pathology
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#exosome Therapeutics Market Trends #exosome Therapeutics Market Growth #exosometherapies #exosometherapies
Investor Series: Opportunities in Women’s Digital Health market Growth Opportunity and Industry Forecast to 2035
The “Investor Series: Opportunities in Women’s Digital Health Market’’ report provides detailed information on the women’s digital health market, covering the core and peripheral women’s digital health solutions
Key Inclusions
An executive summary of the insights captured during our research. It offers a high-level view on the current state of women’s digital health market and its likely evolution in the mid-long term along with the financial activity in this domain.
An introduction to women’s digital health, highlighting some of the key application areas of the FemTech industry. It features various types of women’s digital health products / solutions that have either been marketed / are under development. In addition, the report highlights prominent barriers to the development and success of women’s digital health solutions, and the opinions of representatives from key stakeholder companies involved in this domain.
A detailed analysis of women’s digital health focused companies that were established post-2006, featuring key insights on the observed trends related to the basic company parameters, such as year of establishment, location of headquarters, company size, and type of venture.
An assessment of the various products / solutions, offered by the innovator companies, featuring analysis based on number and types of products. Based on the aforementioned insights, we have developed a quantitative perspective on the relative health (based on the company details, product portfolio, financing activity, estimated revenues and profits) of the different innovator companies that have been described in detail in this report. This analysis is based on a proprietary scoring criterion, informed via secondary research.
An informed perspective on the value proposition of the companies captured in the report based on multiple relevant aspects, namely product-related value, value to patients, developer value and outreach-related value.
A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in providing women’s digital health solutions. It is worth mentioning that this analysis is based on the insights generated from the abovementioned relative health indexing and value proposition analysis.
A detailed analysis of the women's digital health funding women's digital health investment activity that has taken place, since 2011. It also includes category-wise financing trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the innovator companies mentioned in the report. Further, it features a list of the leading investors in women’s digital health, based on their participation in financing activity in this industry segment.
An elaborate review of the overall women’s digital health market from a financial perspective, including detailed fundamental (insights from the balance sheet and key financial ratios) and technical analysis (insights from historical and recent stock price variations as well as analysis using popular stock performance indicators) of financial data of the publicly listed companies within the innovators landscape dataset.
A key acquisition targets analysis, based on the insights generated during the course of this study, highlighting some of the promising early-to-mid stage business ventures that are likely to be acquired / merged.
A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology risks, and others (social, economic, environmental and political risks).
A case study where investors have exited various women’s digital health-related ventures, offering insights on return on investments received (based on availability of data). Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the women’s digital health market.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Solution
Applications / Software
Devices
Services
Therapeutic Application Area
Fetal Health
General Wellness
Menstrual Cycle
Pelvic Care
Reproductive Health / Fertility
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Key Questions Answered
What are the key application areas of the FemTech industry?
Who are the innovators offering women’s digital health solutions?
What type of women’s digital health products / solutions are being offered by the innovator companies?
What are the key value propositions offered by players engaged in the women’s digital health domain?
What is the relative competitiveness of different players offering products / solutions focused on women’s health?
Who are the key investors that are actively supporting the development and commercialization of women’s digital health products / solutions?
What are the anticipated fundamental and technical trends of financial data of publicly listed companies within the innovator landscape?
Who are the potential acquisition targets for investors in the women’s digital health sector?
What are the major risks for investors seeking to tap into the women’s digital health domain?
What is the estimated return on investments received by the investors?
How is the current and future market opportunity related to women’s digital health likely to be distributed across key market segments?
Get more details on the report https://www.rootsanalysis.com/....reports/opportunitie
You may also be interested in the following titles:
Blockchain Technology in Healthcare Market
Autoinjectors
You may also like to learn what our experts are sharing in Roots educational series:
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#Women’sDigitalHealthInvestorSeries #Women’sDigitalHealthMarket #digital HealthFunding #women'sdigitalhealthInvestment #women'shealthInvestors
Satta king | Sattaking | Satta result | Satta king online Satta king live | Satta king result
https://sattakingreal.in/
Satta king is a popular game that is played on daily basis. #satta A lot of #sattaking bet on the different games in the satta king. The results of these games are posted online. The company that runs these games usually fixes the timing of the results so that you https://sattakingreal.in don't have to wait for hours to get the result. But, if you want to get the result faster, you can find a website https://sattakingg.in/
on the internet that will give you the result at once.
Play satta king game becama a rich win lottery in 2023 | #satta King # satta result # satta king up # sattaking # gali result # satta result up # satta # satta king 786 # satta gali # satta king gali # desawar result # faridabaad result # gaziabaad result kin